ASPI ASP Isotopes Inc. Common Stock
USBasic MaterialsAs of 2026-08-24
Why ASPI matters now
ASP Isotopes Inc. Common Stock (ASPI) is a US stock in Basic Materials. The latest InvestLog snapshot shows $3.89 with -2.75% on the session and $489.8M in market capitalization; recent performance reads 1-month +48.35% and YTD +34.21%.
The latest financial table shown here is Q1 2026, with revenue of $4.2M, net income of $-6.9M, and EPS of $-0.06. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -11.0%.
The latest indexable market news headline is "ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth" from MarketBeat.
Additional event context on this page matters because analyst consensus is Buy with a median target of $9.25; recent insider activity includes Ainscow Robert filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
3.01
P/S
22.16
EV/EBITDA
-3.82
DCF Value
$-3.36
FCF Yield
-11.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
17.6%
Operating Margin
-275.3%
Net Margin
-644.4%
ROE
-117.2%
ROA
-29.5%
ROIC
-13.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $4.2M | $-6.9M | $-0.06 |
| Q4 2025 | $16.7M | $-78.7M | $-0.84 |
| FY 2025 | $23.8M | $-175.1M | $-2.11 |
| Q3 2025 | $4.9M | $-12.9M | $-0.15 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$9.50
Target (Median)
$9.25
Target Range
$4.50 - $15.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Basic Materials
Industry
Chemicals
Country
US
Exchange
—
Beta
3.44
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.